These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1047 related items for PubMed ID: 28248111

  • 1. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP, Kulkarni V, Murahari M, Nayak UY, Bhat P, Suvarna V, Dravyakar B.
    Mol Pharm; 2017 Apr 03; 14(4):1231-1242. PubMed ID: 28248111
    [Abstract] [Full Text] [Related]

  • 2. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM, Mishra B.
    AAPS PharmSciTech; 2016 Apr 03; 17(2):272-83. PubMed ID: 26077622
    [Abstract] [Full Text] [Related]

  • 3. Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions.
    Wang D, Li H, Gu J, Guo T, Yang S, Guo Z, Zhang X, Zhu W, Zhang J.
    J Pharm Biomed Anal; 2013 Sep 03; 83():141-8. PubMed ID: 23732534
    [Abstract] [Full Text] [Related]

  • 4. Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.
    Semcheddine F, Guissi Nel I, Liu X, Wu Z, Wang B.
    AAPS PharmSciTech; 2015 Jun 03; 16(3):704-15. PubMed ID: 25511809
    [Abstract] [Full Text] [Related]

  • 5. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov 03; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 6. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling.
    Adhikari S, Daftardar S, Fratev F, Rivera M, Sirimulla S, Alexander K, Boddu SHS.
    Int J Pharm; 2018 Jul 10; 545(1-2):357-365. PubMed ID: 29747001
    [Abstract] [Full Text] [Related]

  • 7. Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity.
    Tang P, Li S, Wang L, Yang H, Yan J, Li H.
    Carbohydr Polym; 2015 Oct 20; 131():297-305. PubMed ID: 26256188
    [Abstract] [Full Text] [Related]

  • 8. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ.
    Eur J Pharm Biopharm; 2007 Jun 20; 66(3):413-21. PubMed ID: 17240129
    [Abstract] [Full Text] [Related]

  • 9. Preparation and comparison of binary and ternary inclusion complexes of aripiprazole using L-arginine/lysine and MβCD/HPβCD by using different molar ratios.
    Awais S, Afridi M, Batool A, Ansari MT, Sultana K, Momal H, Alsanie WF, S Alamri A, Alhomrani M.
    Pak J Pharm Sci; 2024 Jan 20; 37(1(Special)):245-255. PubMed ID: 38747276
    [Abstract] [Full Text] [Related]

  • 10. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
    Sherje A, Londhe V.
    Curr Drug Discov Technol; 2014 Jan 20; 11(4):271-8. PubMed ID: 25578059
    [Abstract] [Full Text] [Related]

  • 11. Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity.
    Yurtdaş-Kırımlıoğlu G.
    Drug Dev Ind Pharm; 2021 Aug 20; 47(8):1261-1278. PubMed ID: 34606394
    [Abstract] [Full Text] [Related]

  • 12. [The study on the preparation and spectroscopic properties of hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex].
    Zhang YM, Li X, Sun CS, Chen CF.
    Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Mar 20; 28(3):711-4. PubMed ID: 18536450
    [Abstract] [Full Text] [Related]

  • 13. Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modeling.
    Lu Y, Guo T, Qi J, Zhang J, Wu W.
    AAPS PharmSciTech; 2012 Dec 20; 13(4):1222-9. PubMed ID: 22968546
    [Abstract] [Full Text] [Related]

  • 14. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
    Lima BDS, Campos CA, da Silva Santos ACR, Santos VCN, Trindade GDGG, Shanmugam S, Pereira EWM, Marreto RN, Duarte MC, Almeida JRGDS, Quintans JSS, Quintans LJ, Araújo AAS.
    Food Chem Toxicol; 2019 Apr 20; 126():15-24. PubMed ID: 30738132
    [Abstract] [Full Text] [Related]

  • 15. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
    Maria DN, Mishra SR, Wang L, Abd-Elgawad AH, Soliman OA, El-Dahan MS, Jablonski MM.
    Curr Drug Deliv; 2017 Sep 06; 14(6):875-886. PubMed ID: 27501714
    [Abstract] [Full Text] [Related]

  • 16. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin.
    Hu L, Zhang H, Song W, Gu D, Hu Q.
    Carbohydr Polym; 2012 Nov 06; 90(4):1719-24. PubMed ID: 22944438
    [Abstract] [Full Text] [Related]

  • 17. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
    Chauhan R, Madan J, Kaushik D, Sardana S, Pandey RS, Sharma R.
    Pharm Dev Technol; 2013 Nov 06; 18(2):313-22. PubMed ID: 21699389
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
    Nie S, Fan X, Peng Y, Yang X, Wang C, Pan W.
    Arch Pharm Res; 2007 Aug 06; 30(8):991-1001. PubMed ID: 17879753
    [Abstract] [Full Text] [Related]

  • 19. Computer-Aided Formulation Design for a Highly Soluble Lutein-Cyclodextrin Multiple-Component Delivery System.
    Zhao Q, Miriyala N, Su Y, Chen W, Gao X, Shao L, Yan R, Li H, Yao X, Cao D, Wang Y, Ouyang D.
    Mol Pharm; 2018 Apr 02; 15(4):1664-1673. PubMed ID: 29505718
    [Abstract] [Full Text] [Related]

  • 20. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Wang S, Ding Y, Yao Y.
    Drug Dev Ind Pharm; 2009 Jul 02; 35(7):808-13. PubMed ID: 19337873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.